Nuzenio

Duchenne

Duchenne news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 22 latest news signals 18 publisher sources 100/100 entity strength

Latest news

Regenxbio Seen on Track for Duchenne Approval as Data Strengthens, RBC Says - marketscreener.commarketscreener.com · Fri, 07 Aug 2026 17:37:18 GMT Greenstone Biosciences Receives NIH Grant To Develop Cardiac Fibrosis Treatments For Duchenne Muscular Dystrophy - Pulse 2.0Pulse 2.0 · Fri, 07 Aug 2026 12:48:12 GMT Greenstone Biosciences Receives NIH R61 Grant to Advance Cardiac Fibrosis Therapeutics for Duchenne Muscular Dystrophy - Business WireBusiness Wire · Thu, 06 Aug 2026 23:35:00 GMT Solid Biosciences Reports Second Quarter 2026 Financial Results and Provides Business Updates - GlobeNewswireGlobeNewswire · Thu, 06 Aug 2026 20:08:47 GMT Expanded access program to bring DMD treatment to patients in 1 US state - Muscular Dystrophy NewsMuscular Dystrophy News · Thu, 06 Aug 2026 19:04:33 GMT Sarepta’s new CEO Michael Severino faces critical milestones to prove growth - Fierce PharmaFierce Pharma · Thu, 06 Aug 2026 15:15:32 GMT New Steroid May Spare Bone Markers Suppressed by Prednisone - MedscapeMedscape · Thu, 06 Aug 2026 12:41:03 GMT Once again, child dies in gene-editing trial in China, rekindling debate on transparency and safety - STATSTAT · Wed, 05 Aug 2026 17:48:28 GMT

Timeline

Fri, 07 Aug 2026 17:37:18 GMTRegenxbio Seen on Track for Duchenne Approval as Data Strengthens, RBC Says - marketscreener.com

Fri, 07 Aug 2026 12:48:12 GMTGreenstone Biosciences Receives NIH Grant To Develop Cardiac Fibrosis Treatments For Duchenne Muscular Dystrophy - Pulse 2.0

Thu, 06 Aug 2026 23:35:00 GMTGreenstone Biosciences Receives NIH R61 Grant to Advance Cardiac Fibrosis Therapeutics for Duchenne Muscular Dystrophy - Business Wire

Thu, 06 Aug 2026 20:08:47 GMTSolid Biosciences Reports Second Quarter 2026 Financial Results and Provides Business Updates - GlobeNewswire

Thu, 06 Aug 2026 19:04:33 GMTExpanded access program to bring DMD treatment to patients in 1 US state - Muscular Dystrophy News

Thu, 06 Aug 2026 15:15:32 GMTSarepta’s new CEO Michael Severino faces critical milestones to prove growth - Fierce Pharma

Related explainers

ElectionsElection stories need careful handling because polls, turnout, legal challenges, and campaign claims can change quickly.HealthHealth stories help readers understand public-health signals, medical research, hospital systems, medicines, disease updates, and safety guidance.HealthcareHealthcare stories can affect personal decisions, so Nuzenio treats them as information that should be checked with original sources and professionals.

Connected entities

FDA11 live mentions Capricor10 live mentions Muscular Dystrophy News6 live mentions Duchenne Muscular Dystrophy4 live mentions Greenstone Biosciences Receives3 live mentions STAT STAT3 live mentions Alabama3 live mentions UC Davis Health3 live mentions Regenxbio Seen2 live mentions Track2 live mentions

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Duchenne.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

18 distinct publisher/source names are currently connected to this entity page.